Your browser doesn't support javascript.
loading
Macrophage-derived nitric oxide initiates T-cell diapedesis and tumor rejection.
Sektioglu, Ibrahim M; Carretero, Rafael; Bender, Noemi; Bogdan, Christian; Garbi, Natalio; Umansky, Viktor; Umansky, Ludmila; Urban, Katharina; von Knebel-Döberitz, Magnus; Somasundaram, Veena; Wink, David; Beckhove, Philipp; Hämmerling, Günter J.
Affiliation
  • Sektioglu IM; Tumor Immunology Program, German Cancer Research Center (DKFZ) , Heidelberg, Germany.
  • Carretero R; Tumor Immunology Program, German Cancer Research Center (DKFZ) , Heidelberg, Germany.
  • Bender N; Tumor Immunology Program, German Cancer Research Center (DKFZ) , Heidelberg, Germany.
  • Bogdan C; Mikrobiologisches Institut - Klinische Mikrobiologie, Immunologie und Hygiene, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Universitätsklinikum Erlangen , Erlangen, Germany.
  • Garbi N; Institutes of Molecular Medicine and Experimental Immunology, University of Bonn , Bonn, Germany.
  • Umansky V; Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany.
  • Umansky L; Immune Monitoring Unit, German Cancer Research Center (DKFZ) , Heidelberg, Germany.
  • Urban K; Immune Monitoring Unit, German Cancer Research Center (DKFZ) , Heidelberg, Germany.
  • von Knebel-Döberitz M; Clinical Cooperation Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Applied Tumor Biology Institute of Pathology, University of Heidelberg, Heidelberg, Germany.
  • Somasundaram V; Cancer and Inflammation Program, National Cancer Institute, NIH , Frederick, MD, USA.
  • Wink D; Cancer and Inflammation Program, National Cancer Institute, NIH , Frederick, MD, USA.
  • Beckhove P; Tumor Immunology Program, German Cancer Research Center (DKFZ), Heidelberg, Germany; Regensburg Center for Interventional Immunology (RCI) and University Medical Center of Regensburg, Regensburg, Germany.
  • Hämmerling GJ; Tumor Immunology Program, German Cancer Research Center (DKFZ) , Heidelberg, Germany.
Oncoimmunology ; 5(10): e1204506, 2016.
Article in En | MEDLINE | ID: mdl-27853636

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Oncoimmunology Year: 2016 Document type: Article Affiliation country: Germany

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Oncoimmunology Year: 2016 Document type: Article Affiliation country: Germany